Brainstorm Cell Therapeutics Inc (OTCPK:BCLI)
$ 1.1628 -0.037 (-3.1%) Market Cap: 12.83 Mil Enterprise Value: 14.18 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Brainstorm Cell Therapeutics Inc (BCLI) Transcripts

  • 1